Literature DB >> 27817039

The carriers of the A/G-G/G allelic combination of the c.2039 A>G and c.-29 G>A FSH receptor polymorphisms retrieve the highest number of oocytes in IVF/ICSI cycles.

Adolfo Allegra1, Angelo Marino2, Stefania Raimondo3, Antonio Maiorana4, Salvatore Gullo5, Piero Scaglione2, Aldo Volpes2, Riccardo Alessandro3.   

Abstract

PURPOSE: The objective of this study was the elucidation of the possible role of the single-nucleotide polymorphisms (SNP) at position -29 and 2039 of the FSH receptor gene (FSHR) as independent predictive markers of ovarian response. Indeed, the tailoring of reproductive treatments is crucial for both maximizing the success of IVF patients and obtaining a reduction in hypo- or hyper-response rates.
METHODS: This prospective, observational study analyzed the association of -29 and 2039 FSHR polymorphisms with the number of retrieved oocytes in 140 patients attending an IVF/ICSI cycle for severe male factors (≤5,000,000 spermatozoa/mL) or tubal factors at the ANDROS Day Surgery Clinic, Palermo, Italy.
RESULTS: The results of this study demonstrate that the genetic combination of A/G for polymorphism c.2039 A>G with G/G for polymorphism c.-29 G>A is significantly associated with the highest number of collected oocytes (p = 0.03). This association was significant even after controlling for the effect of other clinical variables.
CONCLUSIONS: The A/G-G/G allelic variant, identified as an independent variable, if confirmed in a larger number of patients, could be considered as a new genetic biomarker, which could increase the efficacy of prediction models for ovarian stimulation.

Entities:  

Keywords:  COH; FSH receptor polymorphisms; IVF/ICSI; Treatment personalization

Mesh:

Substances:

Year:  2016        PMID: 27817039      PMCID: PMC5306403          DOI: 10.1007/s10815-016-0835-9

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  45 in total

1.  Influence of female bodyweight on IVF outcome: a longitudinal multicentre cohort study of 487 infertile couples.

Authors:  A Pinborg; C Gaarslev; C O Hougaard; A Nyboe Andersen; P K Andersen; J Boivin; L Schmidt
Journal:  Reprod Biomed Online       Date:  2011-06-26       Impact factor: 3.828

2.  Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.

Authors:  Sesh Kamal Sunkara; Vivian Rittenberg; Nick Raine-Fenning; Siladitya Bhattacharya; Javier Zamora; Arri Coomarasamy
Journal:  Hum Reprod       Date:  2011-05-10       Impact factor: 6.918

3.  Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation.

Authors:  Hermann M Behre; Robert R Greb; Andrea Mempel; Barbara Sonntag; Ludwig Kiesel; Petra Kaltwasser; Ewald Seliger; Friedrich Röpke; Jörg Gromoll; Eberhard Nieschlag; Manuela Simoni
Journal:  Pharmacogenet Genomics       Date:  2005-07       Impact factor: 2.089

4.  Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.

Authors:  Danhua Pu; Jie Wu; Jiayin Liu
Journal:  Hum Reprod       Date:  2011-07-21       Impact factor: 6.918

5.  Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.

Authors:  K Aittomäki; J L Lucena; P Pakarinen; P Sistonen; J Tapanainen; J Gromoll; R Kaskikari; E M Sankila; H Lehväslaiho; A R Engel; E Nieschlag; I Huhtaniemi; A de la Chapelle
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

6.  Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism.

Authors:  Swati K Achrekar; Deepak N Modi; Sadhana K Desai; Vijay S Mangoli; Ranjana V Mangoli; Smita D Mahale
Journal:  Reprod Biomed Online       Date:  2009-04       Impact factor: 3.828

7.  Genetic and functional analyses of polymorphisms in the human FSH receptor gene.

Authors:  Satoko Sudo; Masataka Kudo; Shin-ichiro Wada; Osamu Sato; Aaron J W Hsueh; Seiichiro Fujimoto
Journal:  Mol Hum Reprod       Date:  2002-10       Impact factor: 4.025

8.  The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age.

Authors:  A La Marca; E Papaleo; C Alviggi; G Ruvolo; G De Placido; M Candiani; E Cittadini; F De Michele; V Moriondo; V Catellani; A Volpe; M Simoni
Journal:  Hum Reprod       Date:  2013-03-15       Impact factor: 6.918

9.  What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?

Authors:  Murat Berkkanoglu; Kemal Ozgur
Journal:  Fertil Steril       Date:  2009-04-14       Impact factor: 7.329

10.  Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation.

Authors:  Mohammad Hasan Sheikhha; Maryam Eftekhar; Seyed Mehdi Kalantar
Journal:  J Hum Reprod Sci       Date:  2011-05
View more
  3 in total

Review 1.  The Effect of the Allelics of Ser680Asn Polymorphisms of Follicle-Stimulating Hormone Receptor Gene in IVF/ICSI Cycles: a Systematic Review and Meta-analysis.

Authors:  Anastasia Prodromidou; Evangelia Dimitroulia; Depy Mavrogianni; Nikolaos Kathopoulis; Kalliopi I Pappa; Dimitrios Loutradis
Journal:  Reprod Sci       Date:  2022-06-09       Impact factor: 3.060

2.  Association of single-nucleotide polymorphisms in the ESR2 and FSHR genes with poor ovarian response in infertile Jordanian women.

Authors:  Amer Mahmoud Sindiani; Osamah Batiha; Esra'a Al-Zoubi; Sara Khadrawi; Ghadeer Alsoukhni; Ayesha Alkofahi; Nour Alhoda Alahmad; Sherin Shaaban; Eman Alshdaifat; Masood Abu-Halima
Journal:  Clin Exp Reprod Med       Date:  2021-01-28

3.  Effects of FSHR and FSHB Variants on Hormonal Profile and Reproductive Outcomes of Infertile Women With Endometriosis.

Authors:  Bianca Bianco; Flavia Altheman Loureiro; Camila Martins Trevisan; Carla Peluso; Denise Maria Christofolini; Erik Montagna; Antonio Simone Laganà; Caio Parente Barbosa
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-30       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.